International News

At its meeting on 26 August 2014, the Board of Directors of Geistlich Pharma AG reconstituted itself. Dr Andreas Geistlich is the new President of the…

The new website of Geistlich Pharma AG has been live since today. With the re-launch, the information content has been tailored even more specifically…

In 2013, the global economy was once again characterised by uncertainty and reticence. In this difficult environment, Geistlich Pharma AG again…

Innovation is an everyday occurrence at Geistlich. The film “The Art of Innovation” is designed to give a better idea of what this everyday life looks…

Following on from the bone replacement material Geistlich Bio-Oss®, the Japanese authorities have now also granted a licence to Geistlich Bio-Gide®.…

With immediate effect two new laws in the US and France will regulate collaboration between medicine and industry. The goal of both laws is to ensure…

In October 2013, Dr Peter Geistlich, the President of the Board of Directors of Geistlich Pharma AG, together with Geistlich Pharma AG in the USA,…

In September, the 3rd Central Switzerland Economic Forum was held on the Pilatus on the topic of "Education – Innovation – Workforce". Paul Note, CEO…

Researchers of the University of Zurich has presented new results from a long-term study over 12 to 14 years. The study shows that implants placed…

The Osteology Foundation is celebrating its 10th anniversary at the International Symposium in Monaco. Geistlich Pharma, together with Dr. Peter…

Geistlich Biomaterials showed many visitors the innovations in Geistlich products at its 160 m2 stand at the International Dental Show (IDS) in…

Geistlich Pharma AG is able to look back on a varied 2012 with a sense of satisfaction. Its good geographical mix and focus on a long-term strategy…